# Second Opinion Fast-Track Service

**Document Version**: 1.0
**Last Updated**: November 8, 2025
**Owner**: Chief Medical Officer
**Purpose**: Provide rapid access to expert second opinions from world-renowned AATD specialists for patients facing critical treatment decisions‚Äîensuring informed decision-making and optimal outcomes

---

## üìã Table of Contents

1. [Service Overview](#service-overview)
2. [Why Second Opinions Matter](#why-second-opinions-matter)
3. [When to Seek Second Opinion](#when-to-seek-second-opinion)
4. [Fast-Track Process](#fast-track-process)
5. [Expert Panel Network](#expert-panel-network)
6. [Service Delivery Models](#service-delivery-models)
7. [Implementation Plan](#implementation-plan)
8. [Success Metrics](#success-metrics)

---

## Service Overview

### What We Offer

**Mark Egly Foundation Second Opinion Fast-Track Service** connects AATD patients with world-class experts for rapid consultations on critical medical decisions:

**Service Features**:

- ‚úÖ **Rapid Access**: Consultations within 7-14 days (vs. typical 3-6 month wait for top specialists)
- ‚úÖ **Expert Panel**: 20+ leading AATD specialists (pulmonologists, hepatologists, transplant surgeons, genetic counselors)
- ‚úÖ **Comprehensive Review**: Experts review complete medical records (test results, imaging, pathology, treatment history)
- ‚úÖ **Multiple Consultation Formats**: Telemedicine (video), phone, in-person, or written report (patient chooses)
- ‚úÖ **Detailed Report**: Written summary of expert's opinion (diagnosis confirmation, treatment recommendations, alternative options, prognosis)
- ‚úÖ **Care Coordination**: Navigator helps implement recommendations (schedule follow-up, obtain additional tests, coordinate with local doctors)
- ‚úÖ **Subsidized Cost**: Foundation covers portion of consultation fee (reduce financial barrier‚Äîsee Financial Assistance section)

**Who Can Use**:

- AATD patients facing major decisions (transplant evaluation, starting augmentation therapy, clinical trial enrollment, surgery)
- Patients with uncertain diagnosis (suspected AATD, atypical presentation, conflicting test results)
- Patients dissatisfied with current care (treatment not working, symptoms worsening despite treatment, want expert confirmation)

---

### Service Goals

**Year 1** (2026):

- 200 patients receive second opinions
- 10-day average turnaround (from request to consultation)
- 95% patient satisfaction

**Year 3** (2028):

- 1,000 patients/year
- 7-day average turnaround
- 20 expert panel members (expand specialties‚Äîadd transplant surgeons, interventional pulmonologists, rare genotype experts)

**Year 5** (2030):

- 2,500 patients/year
- AI-assisted triage (algorithm reviews records, routes to most appropriate expert)
- Real-time consultations (24-hour turnaround for urgent cases‚Äîe.g., acute liver failure, transplant decision)

---

## Why Second Opinions Matter

### Medical Decision Complexity

**AATD Involves High-Stakes Decisions**:

- **Augmentation therapy**: Start or not? (Costs $100K-$200K/year, weekly infusions‚Äîwant to be sure it's right decision)
- **Lung transplant**: Pursue evaluation? (Life-changing surgery, 5-year survival 50-60%, risks vs. benefits)
- **Liver transplant**: For pediatric patients (neonatal cholestasis‚Äîsome resolve without transplant, some need urgent transplant‚Äîhard call)
- **Clinical trials**: Enroll in gene therapy trial? (Experimental, unknown risks, could be curative‚Äîneed expert guidance)
- **Genetic testing**: Test children? (Carrier screening, ethical considerations, impact on insurability)

**First Doctor May Be Wrong** (Or Not AATD Expert):

- **Misdiagnosis**: 30% of AATD patients initially misdiagnosed (as asthma, COPD, bronchitis‚ÄîAATD not considered)
- **Outdated treatment**: Community doctors may not know latest guidelines (augmentation therapy indications expanded, new transplant criteria)
- **Lack of AATD expertise**: Only ~50 AATD specialists nationwide (most doctors see 0-1 AATD patient in career‚Äîlimited experience)

**Second Opinions Save Lives**:

- **Confirm diagnosis** (catch misdiagnoses‚Äîavoid wrong treatment)
- **Optimize treatment** (experts know nuances‚Äîwhen to start augmentation, which inhaler regimen, transplant timing)
- **Offer alternatives** (first doctor says "only option is transplant"‚Äîexpert may suggest clinical trial, different management)
- **Provide reassurance** (if expert agrees with first doctor‚Äîpatient feels confident proceeding)

---

### Barriers to Second Opinions (Current System)

**Why Patients Don't Get Second Opinions**:

- ‚ùå **Long wait times**: Top specialists have 3-6 month backlogs (patient can't wait‚Äîneeds decision now)
- ‚ùå **Geographic barriers**: AATD experts concentrated in few cities (Denver, Cleveland, Boston‚Äîpatients in rural areas can't travel)
- ‚ùå **Cost**: Second opinion consultations expensive ($500-$2,000‚Äînot always covered by insurance)
- ‚ùå **Complexity**: Patient must coordinate (request records, find expert, schedule appointment, travel‚Äîoverwhelming for sick patient)
- ‚ùå **Fear of offending first doctor**: Patients worry "My doctor will be upset if I seek second opinion" (though ethically, doctors should support)

**Foundation's Fast-Track Service Eliminates These Barriers**

---

### Patient Stories

**Story 1: Transplant Decision**:

- 52-year-old male, ZZ AATD, FEV1 28%, frequent exacerbations (3 hospitalizations past year)
- Local pulmonologist: "You need lung transplant‚ÄîI'm referring you for evaluation"
- Patient scared (transplant = major surgery, risks, lifelong immunosuppression), wants second opinion
- **Without Fast-Track**: Patient calls Cleveland Clinic (top AATD center)‚Äîfirst available appointment is 4 months away. Patient can't wait (deteriorating rapidly‚Äîmay not survive 4 months).
- **With Fast-Track**: Patient contacts Foundation ‚Üí Navigator arranges telemedicine consult with Cleveland Clinic expert (Dr. Stoller) within 1 week. Dr. Stoller reviews records, agrees transplant evaluation warranted, but suggests optimizing medical management first (increase pulmonary rehab, adjust inhalers, treat OSA if present) ‚Üí try for 3-6 months, then re-evaluate. Patient implements changes ‚Üí FEV1 improves to 32%, exacerbations reduce ‚Üí delays transplant 2 years (better quality of life, more time to prepare).

**Story 2: Uncertain Diagnosis**:

- 35-year-old female, low AAT level (40 mg/dL‚Äînormal 150-350), but genotype testing shows MM (normal genotype‚Äîshould have normal AAT)
- Local doctor confused: "Your AAT is low, but you don't have ZZ genotype‚ÄîI don't know what's wrong"
- Patient worried (is it AATD? something else? do I need treatment?)
- **With Fast-Track**: Foundation arranges consult with genetic counselor + AATD geneticist (expert in rare variants). Expert reviews: Finds patient has rare null-null variant (genetic test missed it‚Äîneeds sequencing, not just standard genotype test). Patient has severe AATD (AAT level < 11 ŒºM) ‚Üí needs augmentation therapy. **Outcome**: Correct diagnosis (caught by expert‚Äîwould have been missed by community doctor), started treatment, lung function stabilizes.

**Story 3: Treatment Not Working**:

- 60-year-old male, ZZ AATD, on augmentation therapy 5 years (Prolastin, weekly infusions)
- Despite treatment, FEV1 declining rapidly (70% ‚Üí 50% in 2 years‚Äîfaster than expected)
- Patient: "Is augmentation therapy not working? Should I stop?"
- **With Fast-Track**: Foundation arranges consult with National Jewish Health expert. Expert reviews: Finds patient has low trough AAT levels (< 11 ŒºM‚Äîshould be > 11 during therapy, meaning dose insufficient). Expert recommends: Increase dose (from 60 mg/kg weekly to 120 mg/kg weekly‚Äîdouble dose, off-label but evidence-based for rapid decliners). Patient switches ‚Üí trough levels improve ‚Üí FEV1 decline slows. **Outcome**: Treatment optimized (expert knew advanced strategy‚Äîcommunity doctor didn't).

---

## When to Seek Second Opinion

### Clinical Scenarios (Appropriate for Second Opinion)

**1. Major Treatment Decision**:

- Starting augmentation therapy (lifetime commitment, expensive, want confirmation it's indicated)
- Transplant evaluation (lung or liver‚Äîlife-altering decision)
- Clinical trial enrollment (experimental therapy‚Äîweigh risks/benefits)
- Major surgery (lung volume reduction surgery, liver resection)

**2. Uncertain or Complex Diagnosis**:

- Low AAT level, but unclear genotype (rare variants, genetic testing inconclusive)
- Symptoms atypical for AATD (liver disease in adult ZZ patient‚Äîneed expert to assess)
- Conflicting test results (AAT level normal on one test, low on another‚Äîwhich is correct?)

**3. Treatment Not Working**:

- On augmentation therapy, but FEV1 declining rapidly (is treatment effective? need dose adjustment?)
- Multiple exacerbations despite optimal medical management (what's missing?)
- Side effects from treatment (panniculitis from augmentation‚Äîhow to manage?)

**4. Rare or Severe Presentation**:

- Pediatric AATD (neonatal cholestasis‚Äîneed pediatric hepatologist expert)
- AATD-associated vasculitis (very rare‚Äîneed rheumatology + AATD expert)
- Null-null genotype (ultra-rare‚Äîneed geneticist)

**5. Dissatisfaction with Current Care**:

- Patient feels doctor dismisses concerns, doesn't listen, not knowledgeable about AATD
- Patient wants confirmation they're receiving best care (peace of mind)

**6. Before Irreversible Decision**:

- Stopping augmentation therapy (want expert to confirm it's OK to stop‚Äîbefore discontinuing)
- Declining transplant (want expert to confirm patient is making informed decision)

---

## Fast-Track Process

### Step 1: Patient Requests Second Opinion

**How to Request**:

- **Phone**: Call 1-800-AATD-2nd (Patient Navigator answers)
- **Online**: Submit form (MarkEglyFoundation.org/SecondOpinion‚Äî5-10 min)
- **Referral**: Primary doctor, Patient Navigator, or another Foundation program refers patient

**Initial Screening** (Navigator Assesses):

- Clinical scenario (what decision are you facing?)
- Urgency (routine‚Äî2 weeks OK, vs. urgent‚Äîneed answer within days)
- Medical records availability (do you have recent test results? imaging? doctor notes?)
- Insurance (covered? if not, qualify for financial assistance?)

---

### Step 2: Records Gathering & Pre-Review

**Navigator Obtains Records**:

- Patient authorizes release (HIPAA form‚ÄîFoundation requests records from all providers)
- Navigator collects:
  - **Pulmonary function tests** (FEV1, DLCO, spirometry‚Äîpast 2 years)
  - **Imaging** (chest CT, liver ultrasound‚ÄîDICOM files, radiology reports)
  - **Lab results** (AAT level, genotype, liver enzymes, CBC, CMP)
  - **Doctor notes** (visit summaries, consultation reports, hospital discharge summaries)
  - **Medications** (current medication list)
  - **Treatment history** (augmentation therapy start date, infusions log, hospitalizations)

**Pre-Review** (Navigator Summarizes):

- Navigator creates 1-2 page clinical summary (for expert‚Äîso expert can review efficiently)
- Includes: Demographics, genotype, key test results, treatment history, current question

**Timeline**: 3-5 days (from request to records gathered)

---

### Step 3: Expert Matching & Scheduling

**Navigator Matches to Expert**:

- Based on clinical scenario:
  - **Lung disease questions** ‚Üí Pulmonologist (National Jewish, Cleveland Clinic, Mayo)
  - **Liver disease questions** ‚Üí Hepatologist (UCSF, Mayo, Pittsburgh)
  - **Genetic questions** ‚Üí Genetic counselor, Medical geneticist
  - **Transplant questions** ‚Üí Transplant surgeon or transplant pulmonologist
  - **Rare variant** ‚Üí AATD geneticist, Rare disease specialist

**Scheduling**:

- Navigator contacts expert (directly‚Äîbypasses appointment line, Foundation relationship)
- Requests consultation slot (within 7-14 days)
- Expert agrees (Foundation pays consultation fee‚Äîsee Financial Assistance)

**Patient Notified**:

- Navigator emails patient (consultation scheduled, date/time, expert's name/credentials, format‚Äîvideo, phone, or in-person)

**Timeline**: 2-3 days (from records ready to consultation scheduled)

---

### Step 4: Expert Consultation

**Consultation Formats** (Patient Chooses):

**Option A: Telemedicine (Video Call)**:

- 60-minute video consultation (Zoom, secure HIPAA-compliant)
- Expert reviews records beforehand (comes prepared), discusses with patient
- Patient can bring family member, local doctor (to video call‚Äîcollaborative)

**Option B: Phone Consultation**:

- 30-60 minute phone call (for patients without reliable internet)

**Option C: In-Person Consultation**:

- Patient travels to expert's clinic (Cleveland Clinic, National Jewish, etc.)
- 60-90 minute in-person visit (physical exam, review imaging together)
- Foundation covers travel costs (if financial need‚Äîsee Travel Assistance Program)

**Option D: Written Report Only**:

- Expert reviews records (without real-time discussion), writes detailed report
- Faster (no scheduling needed), lower cost ($300 vs. $500-$1,000 for live consult)
- Good for: Straightforward questions (e.g., "Does my FEV1 indicate transplant evaluation?" vs. complex discussions)

---

### Step 5: Expert's Opinion & Report

**Expert Provides**:

- **Diagnosis confirmation** (agree or disagree with first doctor's diagnosis‚Äîwith rationale)
- **Treatment recommendations** (start augmentation? pursue transplant? adjust medications? enroll in trial?)
- **Alternative options** (if first doctor said "only option is X," expert may suggest Y or Z)
- **Prognosis** (expected disease course, outcomes with/without treatment)
- **Next steps** (what tests/consultations needed, timeline)

**Written Report**:

- Expert dictates or writes detailed report (3-5 pages)
- Sent to patient (within 3-5 days post-consultation)
- Includes: Summary of records reviewed, clinical impression, recommendations, references (peer-reviewed studies supporting recommendations)

---

### Step 6: Navigator Follow-Up & Implementation

**Navigator Helps Implement**:

- Discuss report with patient (explain expert's recommendations, answer questions, address concerns)
- Coordinate with local doctors (send report to patient's pulmonologist, PCP‚Äîensure they're aware of expert's opinion)
- Schedule follow-up tests (if expert recommends CT scan, liver biopsy, etc.‚ÄîNavigator arranges)
- Facilitate referrals (if expert says "You should see hepatologist," Navigator finds one, schedules appointment)

**Timeline**: Ongoing (Navigator remains involved until recommendations implemented)

---

## Expert Panel Network

### Pulmonology Experts (Lung Disease)

**Tier 1 Experts** (World-Renowned):

1. **Dr. James Stoller** (Cleveland Clinic‚Äîworld's leading AATD expert, 200+ publications, AATD researcher, clinician)
2. **Dr. Robert Sandhaus** (National Jewish Health‚ÄîAATD expert, former Alpha-1 Foundation Medical Director)
3. **Dr. Edward Eden** (Weill Cornell‚ÄîAATD researcher, augmentation therapy trials)

**Tier 2 Experts** (Regional Leaders): 4. Mayo Clinic AATD Program (Rochester, MN) 5. UCSF Pulmonology (San Francisco, CA) 6. Massachusetts General Hospital (Boston, MA) 7. Temple University (Philadelphia, PA‚ÄîAATD Center of Excellence) 8. University of Florida (Gainesville, FL‚ÄîAATD Registry site)

---

### Hepatology Experts (Liver Disease)

**Tier 1 Experts**:

1. **Dr. Jayant Talwalkar** (Mayo Clinic‚ÄîAATD liver disease, transplant hepatology)
2. **UCSF Liver Transplant Team** (San Francisco‚Äîpremier liver transplant center, AATD expertise)
3. **Dr. David Perlmutter** (UPMC‚Äîpediatric AATD liver disease, researcher)

**Tier 2 Experts**: 4. Cleveland Clinic Liver Center 5. Baylor Liver Transplant (Houston, TX) 6. Northwestern Liver Transplant (Chicago, IL)

---

### Genetic Counseling Experts

1. **Certified Genetic Counselors** (specializing in AATD‚Äî10+ counselors nationwide)
2. **Medical Geneticists** (for rare variant cases‚ÄîBaylor Genetics, GeneDx, Ambry)

---

### Transplant Surgery Experts

**Lung Transplant**:

1. Cleveland Clinic Lung Transplant Program
2. Duke Lung Transplant (Durham, NC)
3. UCSF Lung Transplant (San Francisco, CA)

**Liver Transplant**:

1. UCSF Liver Transplant
2. Mayo Clinic Liver Transplant (Rochester, MN; Scottsdale, AZ; Jacksonville, FL)
3. UPMC Liver Transplant (Pittsburgh, PA)

---

### Pediatric Experts

1. **Cincinnati Children's Hospital** (Pediatric hepatology, AATD liver disease)
2. **Boston Children's Hospital** (Pediatric pulmonology, genetics)
3. **Lucile Packard Children's Hospital at Stanford** (Pediatric hepatology, liver transplant)

---

### Total Panel (Year 1): 20 Experts

**Expansion** (Year 3+): Add 10 more experts (cover rare specialties‚ÄîAATD vasculitis, panniculitis, rare genotypes)

---

## Service Delivery Models

### Model 1: Direct-to-Expert (Standard)

**Process**:

- Foundation arranges consultation (Navigator ‚Üí Expert)
- Patient pays expert directly (consultation fee $500-$1,500‚Äîexpert sets rate)
- Foundation subsidizes (reimburses patient $300-$500‚Äîsee Financial Assistance)

**Pros**:

- Expert compensated fairly (ensures participation, high-quality service)
- Patient pays directly (feels like "their" doctor‚Äînot Foundation intermediary)

**Cons**:

- Financial barrier (patient must pay upfront, wait for reimbursement)

---

### Model 2: Foundation-Paid (Premium)

**Process**:

- Foundation pays expert directly (consultation fee‚Äî$500-$1,500)
- Patient pays nothing (or small copay‚Äî$50-$100)

**Pros**:

- No financial barrier (accessible to all patients‚Äîregardless of ability to pay)
- Simpler (patient doesn't handle payments)

**Cons**:

- Higher Foundation cost ($500-$1,500 per consult vs. $300-$500 subsidy)

**When Used**:

- Financial hardship cases (uninsured, low-income‚Äîqualify for 100% Foundation coverage)
- Urgent cases (Foundation wants to ensure patient gets opinion‚Äîremoves barriers)

---

### Model 3: Insurance-Billed (Future‚ÄîYear 3+)

**Process**:

- Expert bills patient's insurance (as "specialist consultation"‚ÄîCPT code 99205)
- Insurance covers (minus patient copay‚Äî$30-$100)
- Foundation covers copay (if patient qualifies for financial assistance)

**Pros**:

- Sustainable (insurance pays‚ÄîFoundation only covers copays, not full fee)
- Accessible (patients with insurance don't pay out-of-pocket)

**Cons**:

- Complex (requires in-network agreements, coding, billing‚Äîtakes time to set up)

**Implementation Timeline**: Year 3 (once program established, negotiate insurance contracts)

---

## Financial Assistance

### Subsidized Consultation Fees

**Standard Subsidy** (All Patients):

- Foundation covers $300 per second opinion consultation
- Patient pays balance (e.g., if expert charges $800, patient pays $500, Foundation pays $300)

**Enhanced Subsidy** (Financial Hardship):

- Income < 200% FPL (~$60K for family of 4) ‚Üí Foundation covers 100% of consultation fee
- Uninsured ‚Üí Foundation covers 100%

---

### Travel Assistance (If In-Person Consult)

**Eligible Expenses**:

- Airfare, hotel, meals (if patient travels to expert's clinic)
- Up to $1,500 per consultation (see Medical Travel Assistance Program)

---

### Year 1 Budget: $150K

**Assumptions**:

- 200 second opinions (Year 1 goal)
- Average expert fee: $800
- Foundation pays: $300/consult (standard subsidy) + $500/consult for 50 financial hardship cases
- **Total**: (150 √ó $300) + (50 √ó $800) = $45K + $40K = $85K (consultation subsidies)
- **Plus**: Travel assistance ($20K), Navigator staff time ($40K), marketing ($5K)
- **Total Budget**: $150K

---

## Implementation Plan

### Phase 1: Expert Recruitment (Months 1-3)

**Outreach**:

- Foundation contacts experts (pulmonologists, hepatologists at AATD Centers)
- Pitch: "We're launching second opinion service‚Äîwill you participate? We'll send you patients, pay consultation fee, streamline process."

**Contracting**:

- Expert agrees to participation (sign MOU‚Äîmemorandum of understanding)
- Set consultation fee ($500-$1,500‚Äîexpert determines, Foundation agrees)
- Commitment: See Foundation-referred patients within 2 weeks (expedited access)

**Goal**: Recruit 20 experts (10 pulmonologists, 5 hepatologists, 5 other specialists)

---

### Phase 2: Process Development (Months 4-6)

**Build Systems**:

- Records request protocol (HIPAA forms, how to contact doctors' offices, tracking system)
- Scheduling system (Navigator ‚Üí Expert coordination‚Äîcalendar management, reminders)
- Consultation formats (video platform‚ÄîHIPAA-compliant Zoom, phone scripts, written report templates)
- Payment processing (how Foundation reimburses patients, pays experts)

**Train Staff**:

- Hire 1 dedicated Navigator (Second Opinion Coordinator‚Äî$80K/year)
- Train on clinical triage (which expert for which scenario), expert coordination, records gathering

---

### Phase 3: Pilot Launch (Months 7-9)

**Recruit 20 Pilot Patients**:

- Foundation mailing list (identify patients facing major decisions‚Äîtransplant, starting therapy)
- Offer free second opinion (pilot‚ÄîFoundation covers 100%, get feedback)

**Test Process**:

- Navigator coordinates (request to consultation‚Äîmeasure timeline, identify bottlenecks)
- Gather feedback (patient satisfaction, expert satisfaction, process improvements)

---

### Phase 4: Public Launch (Month 10)

**Marketing**:

- Announce service (Foundation website, newsletter, social media, press release)
- Target: Patients facing major decisions (transplant evaluation, augmentation therapy decision, uncertain diagnosis)

**Goal**: 200 second opinions (Year 1)

---

### Phase 5: Scale & Optimize (Year 2+)

**Expand Expert Panel** (to 30 experts‚ÄîYear 2):

- Add rare specialties (transplant surgeons, pediatric experts, rare variant geneticists)

**Reduce Turnaround** (to 7 days‚ÄîYear 2):

- Streamline records gathering (EHR integration‚Äîauto-pull records from patient's Medical Records Portal)
- Standing consultation slots (experts reserve Friday afternoons for Foundation second opinions‚Äîno scheduling delays)

**Insurance Billing** (Year 3):

- Negotiate contracts (with major insurers‚ÄîAetna, UHC, BCBS)
- Bill insurance (sustainable model‚ÄîFoundation only covers copays)

---

## Success Metrics

### Track Quarterly

**Volume**:

- # of second opinions requested (total, per month)
- # of consultations completed (vs. requested‚Äîconversion rate)

**Timeliness**:

- Average turnaround (days from request to consultation)
- % completed within 14 days (goal: 90%+)

**Patient Satisfaction**:

- 5-star rating (quality of expert's opinion, helpfulness of Navigator, value of service)
- Net Promoter Score (NPS‚Äîwould you recommend?)

**Clinical Impact**:

- % of cases where expert's opinion differed from first doctor (assess value-add‚Äîif always agree, second opinion less necessary)
- % of cases where patient changed course (based on expert's opinion‚Äîe.g., delayed transplant, started treatment)

**Financial**:

- Average consultation cost (expert fee + subsidy + travel)
- Cost per patient served (program efficiency)

---

### Year 1 Targets

**Volume**:

- 200 second opinions completed

**Timeliness**:

- 10-day average turnaround
- 85% completed within 14 days

**Satisfaction**:

- 4.8+ average rating (5-star scale)
- NPS 85+ (highly satisfied)

**Impact**:

- 40% of cases: Expert's opinion differed from first doctor (substantial value-add)
- 30% of cases: Patient changed treatment course (based on expert's opinion‚Äîdemonstrates impact)

---

## Summary

**Mark Egly Foundation Second Opinion Fast-Track Service**:

- ‚úÖ **Rapid Access**: Consultations within 7-14 days (vs. 3-6 months typical wait)
- ‚úÖ **Expert Panel**: 20+ world-renowned AATD specialists (pulmonologists, hepatologists, geneticists, transplant surgeons)
- ‚úÖ **Comprehensive Review**: Experts review complete records, provide detailed recommendations
- ‚úÖ **Multiple Formats**: Video, phone, in-person, or written report (patient chooses)
- ‚úÖ **Financial Assistance**: Foundation subsidizes consultation fees ($300 standard, 100% for financial hardship)
- ‚úÖ **Care Coordination**: Navigator helps implement expert's recommendations

**This service ensures AATD patients make informed decisions**:

- **Critical choices** (transplant, starting augmentation, clinical trials) ‚Üí deserve expert input
- **First doctor may lack AATD expertise** (rare disease‚Äîcommunity doctors have limited experience)
- **Second opinions save lives** (catch misdiagnoses, optimize treatment, offer alternatives)

**Fast-Track removes barriers** (long waits, geographic access, cost, complexity) ‚Üí every AATD patient can access expert opinion when needed

**"Empowering patients with expert knowledge for life's biggest decisions."**

---

**Need a Second Opinion?**

**Mark Egly Foundation Second Opinion Fast-Track Service**
üìû Phone: 1-800-AATD-2nd
üìß Email: secondopinion@markeglyfoundation.org
üåê Website: MarkEglyFoundation.org/SecondOpinion

---

**Approved by**: Board of Directors
**Effective Date**: January 1, 2026
**Review Date**: Annually
**Version**: 1.0

---

_"Expert guidance when it matters most."_

**‚Äî Mark Egly Foundation**
